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Post radiation injuryAbstract Purpose: This study aims to evaluate the role of MR spectroscopy in the detection of
recurrent glioma and differentiation from post radiation injury.
Patients and methods: 32 patients (20 males and 12 females) complaining of different neurological
symptoms were enrolled prospectively in this study between September 2011 and December 2013.
These patients were selected on the basis that they were known patients with pathologically proved
glioma who underwent radiotherapy. All patients underwent standard MRI examination and MR
spectroscopy.
Results: This study included 32 patients, twenty four patients (75%) proved histologically to be of
recurrent glioma (group I) and 8 cases (25%) diagnosed as post radiation injury (group II).
Peri-tumoral inﬁltration was present in 18 cases (56.25%) of recurrent glioma. Signiﬁcantly
increased Cho/Cr and Cho/NAA ratios were observed in neoplastic (n= 24) compared with
non-neoplastic lesions (n= 8). Presence of lactate and lipid yielded correct classiﬁcation as
neoplastic and non-neoplastic lesions.
Conclusion: Magnetic resonance spectroscopy is a useful tool for the detection of recurrent glioma
and differentiation from post radiation injury.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.1. Introduction
Distinguishing between radiation necrosis and tumoral recur-
rence represents a difﬁcult diagnostic challenge. Radio-
necrosis at tumor bed may mimic recurrent glioma, while
any radiation-induced lesions detected distant to the primary
tumor site may be misinterpreted as multifocal glioma (1).
Table 1 Histopathological diagnosis of 32 patients suspected
of recurrent glioma.
Final diagnosis No. of patients %
Recurrent glioma (group I) 24 75
-Glioblastoma multiformis 16
-Anaplastic astrocytoma 7
-Low grade glioma 1
Post radiation injury (group II) 8 25
Total 32 100
1234 M.F. Sherif et al.Increasingly aggressive radiation treatment protocols are
being used in the hope of improving patient survival rates.
These regimens can lead to overlap between effective and neu-
rotoxic doses of radiation (2).
MR spectroscopy is providing biochemical information
about proliferative tumor activity and has been proposed asFig. 1 Recurrent glioma. A ﬁfty year old female with a history of left
low grade astrocytoma managed by radiotherapy. After one year she pr
(A) Axial T2 WI of the brain revealed abnormal hyperintense signal
edema. (B) Axial T1 WI of the brain revealed abnormal hypo intense s
(C) Post contrast T1 WI of the brain showed no signiﬁcant enhanceme
single voxel technique showing increased Cho peak and decreased Cr
Cho/Cr ratio (1.9) with, prominent lactate doublet and no signiﬁcant in
Cho/Cr ratio about 1.3, suggesting no inﬁltration in the peri-lesionalalternative modality for differentiating recurrent tumor from
radiation injury (3,4).
Magnetic resonance spectroscopy (MRS) can be used to
serially monitor biochemical changes in tumors, stroke, epi-
lepsy, metabolic disorders, infections, and neurodegenerative
diseases. To get an accurate assessment of the tumor chemis-
try, avoiding areas of necrosis, hemorrhage, calciﬁcation, cysts
or bone is mandatory (5,6).
MR spectroscopy can be performed within 8–10 min and
can be added on to conventional MR imaging protocols (7).2. Aim of the work
The aim of the work is to evaluate the role of MR spectros-
copy in the detection of recurrent glioma and differentiation
from post radiation injury in the whole area of signal alter-
ation within irradiated region.temporoparietal space occupying lesion, proved by biopsy to be of
esented with severe headache with vomiting and right hemiparesis.
intensity at the left temporo-parietal region with mild peri-focal
ignal intensity at the left temporo-parietal region with mass effect.
nt of the previously noted lesion. (D) MRS done with long TE and
and NAA peaks with elevated Cho/NAA ratio (2.2) and elevated
crease in lipid peak. (E) Peri-lesional MRS using long TE revealed
area.
Fig. 2 Recurrent glioma. A ﬁfty year old male with a history of left parieto-occipital anaplastic astrocytoma managed by surgical
resection and radiotherapy. One year later he presented with headache and right sided weakness. (A and B) Post contrast axial T1 WI
showing heterogeneously enhancing lesion seen at the left occipito-parietal region with mass effect in the form of slightly effaced related
cortical sulci. (C) Voxel localization. (D and E) MRS was done with long and short TE using multi-voxel technique and reveals markedly
elevated Cho and decreased both Cr and NAA peaks and increased Cho/NAA ratio (4) and markedly increased Cho/Cr ratio (6.5) with
mildly elevated lactate peak and mild increase in the lipid peak is also noted. (F) Peri-lesional voxels using long TE showed Cho/Cr ratio
3.1, denoting inﬁltration.
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This prospective study includes 32 patients with the history of
previously treated brain tumors, 20 males and 12 females (age
range 23–65 years; mean age, 44 years). All patients included
in this study received radiation therapy. All patients came to
our institute in the period between September 2011 and
December 2013, presented with different neurological symp-
toms. In 18 patients histopathology was available through sur-
gical removal of tumor while stereotactic biopsy was done in
14 patients. Histological ﬁndings revealed 24 patients with
recurrent glioma (group I) including 16 patients with glioblas-
toma multiformis, one patient with low grade glioma and 7
patients with anaplastic astrocytoma. Eight patients proved
to have post radiation changes (group II). The interval
between radiation therapy and MRS ranged between 5 and
11 months. On follow up MRI, the area of signal alteration
at or near the site of original tumor within the previously irra-
diated area was examined by MR spectroscopy. The study wasapproved by the local ethics committee at our institution and
informed consents were obtained from all patients.
4. Methods
4.1. MRI examination of brain
All the patients were evaluated by standard brain MRI proto-
col at our institution using a 1.5T. MRI machine (GE Signa
1.5T, GEMSOW), the protocol includes a 3 plane localizer,
Axial & Sagittal T1WI, Axial T2 WI, and Axial ﬂuid attenua-
tion inversion recovery (FLAIR). Post contrast T1WI in axial,
coronal and sagittal planes using Gadolinium-DTPA (0.2 mg/
kg) was done. A slice thickness of 5 and 4 mm spacing was
used.
Point resolved spectroscopy (PRESS) technique was
applied using the long and short TE (144 and 35 ms) respec-
tively. Sampling analysis was performed by the Multi voxel
MR spectroscopic technique (MVS) in all patients, 2 or 3 were
Fig. 3 Recurrent glioma. A sixty-ﬁve year old female with a history of left frontal glioblastoma multiformis managed by surgical
resection and radiotherapy. Seven months later she presented with severe headache, vomiting and right hemi-paresis. (A) Axial T2 WI
showing abnormal heterogonous signal intensity seen at the left frontal region with surrounding mild peri-focal edema and causing mass
effect. (B) Axial T1 WI showing hypointense signal in the left frontal region. (C) Post-contrast axial T1 WI showing heterogeneous
enhancement of the previously noted lesion. (D and E) MRS was done with short and long TE and reveals markedly elevated Cho and
decreased both Cr and NAA peaks and elevated Cho/NAA ratio (6) and increased Cho/Cr ratio (4.4) with elevated lactate peak and an
increase in the lipid peak is also noted. (F) Peri-lesional MRS using long TE revealed elevated Cho/Cr ratio (2.1), denoting inﬁltration.
1236 M.F. Sherif et al.positioned in the solid parts of the lesions guided by enhance-
ment in post contrast T1WIs avoiding areas that showed signs
of hemorrhage or necrosis, also avoiding contamination from
nearby bone or CSF spaces, the voxel size ranged from
1 · 1 · 1 cm3 to 2 · 2 · 2 cm3, other similar voxels (2 or 3) were
placed in peri lesional edema. A voxel was positioned in the
contralateral normal brain white matter to obtain a reference
spectrum. Choline/Creatine and Choline/N-Acetyl Aspartate
ratios were calculated for the tumor and peri tumoral edema.
Lipid and lactate peaks were read at 1.3 ppm on long and short
TE sequences as present or absent. Surgical resection was per-
formed in 18 patients and stereotactic biopsy in 14 patients, the
resected specimens were evaluated by histopathology.
Statistical analysis was performed using the Mann–Whitney
U test to compareMRS ratios in recurrent glioma and post radi-
ation necrosis, Chi-square test was performed on the lipid peak
in long and short TE, p value of <0.05 was considered
statistically signiﬁcant. Software used was Minitab V.17
(Minitab Inc. USA).5. Results
Depending upon histopathological examination (Table 1) 24
cases (75%) were found to be of recurrent glioma (group I)
and 8 cases (25%) diagnosed as post radiation injury (group
II).
On T1-weighted images with Gadolinium DTPA (Gd-
DTPA), 31 cases showed variable contrast enhanced lesions
while one case of low grade glioma had no area of contrast
enhancement (case 1).
MR spectroscopy revealed 25 patients with pathological
spectra of recurrent/residual tumors, 24 patients with enhanc-
ing lesions (case 2 and 3) while one revealed no enhancement
within lesional area at intralesional voxels (Case 1). In eighteen
of these cases, MR spectroscopy revealed perilesional inﬁltra-
tion in voxels outside the area of enhancement (case 2 and
3). The case presented with no enhancement within the lesion
on Gd-DTPA enhancing images elicited spectra characteristic
for tumor (case 1) with no perilesional inﬁltration. This
Fig. 4 Post radiation injury. A thirty-eight year old male with a history of right parieto-occipital glioma managed by surgical resection
and radiotherapy. Nine months later he presented with severe headache. (A and B) Axial FLAIR WIs showing abnormal heterogeneous
signal intensity seen at the right parieto-occipital region with mild peri-focal edema and negative mass effect upon the related right lateral
ventricle. (C) Voxel localization. (D and E) Intra-lesional MRS using long (left image) and short TE and multi-voxel technique showing
elevated Cho peak with decreased Cr and NAA peaks and increased Cho/NAA ratio (2.36) and increased Cho/Cr ratio (1.6) and increased
lipid peak at 0.8 ppm with prominent lactate peak. (F) Peri-lesional voxels using short TE showing Cho/Cr ratio 0.98, suggesting no
inﬁltration in the peri-lesional area as well.
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Pathological MR spectra characteristic for recurrent/residual
tumor revealed a highly elevated Choline peak (n= 22),
marked depressed NAA (n= 23) and elevated lipid/lactate
peaks (n= 12). Pathological spectra denoting post radiation
injury (7 cases) carry the following criteria; mild elevated cho-
line peak, mild depressed NAA peak and slight elevation of
lipid/lactate peaks (Figs. 1–5).
The values of Cho/Cr ratio of the lesional area were lower
in post radiation injury (1.37 ± 0.30) than recurrent gliomas
(4.41 ± 0.65) (Table 2). A statistically signiﬁcant difference
was seen between intralesional Cho/Cr ratio values in post
radiation injury versus recurrent gliomas with p= 0.0003
and p= 0.019 respectively. Cho/Cr ratio of the perilesional
area was higher in recurrent gliomas (2.213 ± 0.85) than post
radiation injury (1.267 ± 0.333). Perilesional inﬁltration was
detected in 18 patients out of 24 patients in group I (case 2
and 3). No peritumoral inﬁltration could be detected at casesof post radiation injury (cases 4 and 5) A statistically signiﬁ-
cant difference was seen between Cho/Cr ratio values in post
radiation injury versus recurrent glioma with p= 0.0225 and
p= 0.0139 respectively (Table 2).
The values of Cho/NAA ratio of the suspected lesional area
were lower in post radiation injury (1.89 ± 0.30) than recur-
rent gliomas (7.466 ± 1.16) (Table 3). A statistically signiﬁcant
difference was seen between the values of Cho/NAA ratio in
post radiation injury versus recurrent gliomas with
p= 0.0003 and p= 0.019 respectively. Cho/NAA ratio of
the perilesional area was higher in recurrent gliomas
(2.855 ± 0.92) than post radiation injury (1.19 ± 0.17). Perile-
sional inﬁltration was detected in 18 patients out of 24 patients
in group I. A statistically signiﬁcant difference was seen
between Cho/NAA ratio values as shown in Table 3.
Both long and short TE (144 and 35 ms) respectively were
used to evaluate the presence of lactate and lipid. The lactate
peak was well demonstrated on long TE while the lipid peak
Fig. 5 Post radiation injury. A forty-ﬁve year old female with a history of right frontal astrocytoma managed by radiotherapy. Eight
months later she presented with severe headache. (A) Axial T2 WI showing heterogeneous hyperintense signal in the right frontal region,
surrounded by mild peri-focal edema. (B) Axial T1 WI showing hypointense signal in the right frontal region. (C) Post-contrast axial T1
WI showing mild enhancement of the previously noted lesion. (D) Post-contrast sagittal T1 WI showed the enhancement of the lesion. (E)
Intra-lesional MRS using long TE and single voxel technique showed elevated Cho peak with slightly decreased NAA and Cr peaks and
elevated Cho/NAA ratio (1.9) and mildly increased Cho/Cr ratio (1.4) with no signiﬁcant increase in either lactate or lipid peaks. (F) Peri-
lesional MRS using long TE revealed Cho/Cr ratio about 1.4, suggesting no inﬁltration in the peri-lesional area as well.
Table 4 Showing lipid and lactate peaks on long TE 144 ms.
Lipid Lip./Lact Lactate None
Recurrent glioma 8 4 10 2
Post radiation injury 5 1 2 –
Table 3 Showing Cho/NAA ratios in lesional and perilesional
regions of the cases on long TE (144 ms).
Recurrent glioma Post radiation injury
Cho/NAA intralesional 7.466 + 1.16 1.89 + 0.30
Cho/NAA perilesional 2.855 + 0.92 1.19 + 0.17
Table 2 Showing Cho/Cr ratios in lesional and perilesional
regions of the cases on long TE (144 ms).
Recurrent glioma Post radiation injury
Cho/Cr intralesional 4.41 + 0.65 1.37 + 0.30
Cho/Cr perilesional 2.213 + 0.85 1.267 + 0.333
1238 M.F. Sherif et al.was much more evident on short TE. Chi square test showed a
statistically signiﬁcant difference between the presence of lipid
peak in recurrent glioma and post radiation injury on both
long and short TE p= 0.02 and p= 0.47 respectively.
On long TE (144 ms), lactate peak alone was seen in 12
cases including 10 recurrent glioma and 2 post radiation necro-
sis (Table 4) while combined existence of Lip./Lact was seen in
5 cases including 4 cases of recurrent glioma and one case of
post radiation. Lipid peak alone was seen in 13 cases including
8 recurrent glioma and 5 post radiation necrosis. Lactate peak
was less evident on short TE (35 ms) (Table 5).Twenty-four of the 25 patients diagnosed on MRS as recur-
rent/residual tumor proved to be correctly diagnosed on com-
parison with the histopathological study. Only one lesion was
Table 5 Showing lipid and lactate peaks on short TE 35 ms.
Lipid Lip./Lact Lactate None
Recurrent glioma 14 7 1 2
Post radiation injury 6 2 – –
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injury on histopathology. The combination of Cho/Cr and
Cho/NAA ratios resulted in sensitivity = 100%, speciﬁc-
ity = 88.8%, accuracy = 96.6%, PPV = 96% and NPV=
100%.
6. Discussion
Among the non invasive methods that are available for diag-
nosing intracranial tumors, MRS has been used in attempts
to differentiate tumor from radiation necrosis (8).
However the study of Weybright et al. (8) and Rock et al.
(9) revealed that the ability of MRS in detecting tumor was
seen not only in the contrast-enhancing regions but also, even
more important, outside this area in 38% of patients with
recurrent tumor. This ability of multi voxel spectroscopic
imaging to detect tumor tissue outside the area of contrast
enhancement in the same acquisition leads to an increase in
the chance of discovering tumor recurrence and also change
the options for further treatment, this is matching with the
present study as 18 patients (75%) out of 24 patients in group
I have peri-lesional inﬁltration.
This study showed statistically signiﬁcant difference
between intralesional Cho/Cr ratio values in post radiation
injury versus recurrent gliomas with p= 0.0003 and
p= 0.019 respectively. This is in agreement with Zeng et al.
(10) who found that Cho/Cr ratios are signiﬁcantly higher in
recurrent tumors than in radiation injury.
The current study revealed a statistically signiﬁcant differ-
ence between intralesional and perilesional Cho/Cr ratio val-
ues in post radiation injury versus recurrent gliomas and this
is in agreement with Smith et al. (11) and Server et al. (12)
who developed a method using alterations in ratios of standard
brain metabolites-choline (Cho), creatine (Cr), and N-acetylas-
partate (NAA)-to predict the probability of tumor recurrence
in patients previously treated for brain tumors and developing
new contrast-enhancing lesions. Elevations of metabolic ratios
Cho/Cr were found in patients with recurrent tumor more than
those with post-radiation change.
Narayana et al. (13) used Cho/Cr ratio as a marker for
tumor deﬁnition. In the present study Cho/NAA ratio was
able to discriminate between recurrent/residual tumor and
radiation injury. Large prospective studies in the future using
sophisticated prediction models, new methods like 3D MRS,
and target-guided biopsies with histologic conﬁrmation are
needed to reach a consensus about the true value of MRS as
a method of differentiating recurrent/residual tumor from
radiation injury as told by Sundgren (14). The 3D MRS tech-
nique provides full lesion coverage, higher spatial resolution,
as well as including surrounding and contralateral brain
regions as stated by Horska´ (15).
Lipid peaks were seen in recurrent glioma on both long TE
(144 ms) and short TE (35 ms) sequences however the peakswere higher on short TE sequences. A statistically signiﬁcant
difference between the presence of a Lipid peak between recur-
rent gliomas and post radiation injury on both short and long
TE sequences was seen. This agreed with Shokry (16), Opstad
et al. (17) and van der Graaf (18) who stated that lipid peaks
are detected at recurrent glioma on short and long TE with a
statistically signiﬁcant difference between the presence of a
Lipid peak between recurrent gliomas and post radiation
injury on both short and long TE sequences was seen.
Lactate peak was seen on long TE sequences (TE 144) in 10
cases of recurrent glioma and 2 cases of post radiation injury.
Law et al. (19) reported the presence of lipids and lactate peaks
in recurrent glioma. Lipid and lactate presence correlates with
necrosis in post radiation injury (19).
The limitation and recommendation of this study:
- Long term follow up is needed as well as statistical analysis
of sample in the form of survival analysis.
In conclusion, Multi-voxel Magnetic resonance spectros-
copy is useful in the evaluation of recurrence of glioma, also
allows better delineation of tumor margin and extent and dif-
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